China Traditional Chinese Medicine Holdings Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	2.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	5.8yrs

Jüngste Management Updates

Recent updates

China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable

Jan 04

Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

Oct 23

Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Aug 23

Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

May 22

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year

Dec 08

These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively

Sep 05

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially

Jul 20

Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Jul 18

Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Jun 01

Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

Apr 28

Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Feb 14

Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Jan 11

Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

Dec 05

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate

Oct 29

I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease

Oct 11

These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Reasonably Well

Aug 24

Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?

Jul 13

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jun 25

Does China Traditional Chinese Medicine Holdings (HKG:570) Deserve A Spot On Your Watchlist?

Apr 04

Are Investors Undervaluing China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) By 30%?

Mar 15

China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 22

China Traditional Chinese Medicine Holdings (HKG:570) Shareholders Have Enjoyed A 19% Share Price Gain

Feb 01

What Percentage Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Do Insiders Own?

Dec 18

Is China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Trading At A 33% Discount?

Dec 03

Declining Stock and Decent Financials: Is The Market Wrong About China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)?

Nov 18

Geschäftsführer

China Traditional Chinese Medicine Holdings hat keinen Geschäftsführer, oder es liegen keine verfügbaren Daten vor.

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jun Yang	Chairman	less than a year	keine Daten	keine Daten
Hongjian Li	President & Executive Director	less than a year	keine Daten	keine Daten
Lixin Shen	VP & Financial Director	3.2yrs	keine Daten	keine Daten
Dongji Zhao	VP, Joint Company Secretary	7.3yrs	CN¥1.56m	keine Daten
Sau Mei Ng	Joint Company Secretary	2.7yrs	keine Daten	keine Daten

2.7yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrenes Management: 570Das Führungsteam des Unternehmens gilt als erfahren (2.7 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Jun Yang	Chairman	less than a year	keine Daten	keine Daten
Hongjian Li	President & Executive Director	less than a year	keine Daten	keine Daten
Rong Xie	Independent Non-Executive Director	11.8yrs	CN¥279.00k	keine Daten
Ling Qin	Independent Non-Executive Director	5.8yrs	CN¥279.00k	keine Daten
Tze Shan Yu	Independent Non-Executive Director	11yrs	CN¥279.00k	keine Daten
Weidong Li	Independent Non-Executive Director	5.8yrs	CN¥279.00k	keine Daten
Wenming Yang	Non-Executive Director	5.9yrs	CN¥2.60m	keine Daten
Binghua Yang	Non-Executive Director	5.9yrs	keine Daten	keine Daten
Xueren Cheng	Non-Executive Director	2.7yrs	CN¥2.49m	keine Daten
Ru Li	Non-Executive Director	5.8yrs	keine Daten	keine Daten
Qingxin Meng	Non-Executive Director	2yrs	keine Daten	keine Daten
Kan Wang	Non-Executive Director	5.9yrs	keine Daten	keine Daten

5.8yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrener Vorstand: 570Die Vorstandsmitglieder gelten als erfahren (5.8 Jahre durchschnittliche Amtszeit).

China Traditional Chinese Medicine Holdings Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments

China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes

China Traditional Chinese Medicine Holdings Co. Limited, Annual General Meeting, Jun 14, 2024

Less than half of directors are independent

China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023

China Traditional Chinese Medicine Holdings Co. Limited Announces Management Changes

Recent updates

Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others.

Sinopharm Common Wealth Company Limited cancelled the acquisition of 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) from China Asset Management Co. Ltd., China Asset Management (Hong Kong) Limited and others.

First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023)

China Traditional Chinese Medicine Holdings Co. Limited Announces Executive, Board and Committee Appointments

Consensus EPS estimates fall by 31%

New major risk - Revenue and earnings growth

First half 2024 earnings released: EPS: CN¥0.042 (vs CN¥0.12 in 1H 2023)

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2024 Results on Aug 28, 2024

Investor sentiment deteriorates as stock falls 15%

China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes

China Traditional Chinese Medicine Holdings Co. Limited, Annual General Meeting, Jun 14, 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improves as stock rises 26%

New minor risk - Share price stability

Less than half of directors are independent

Investor sentiment improves as stock rises 15%

China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

Investor sentiment deteriorates as stock falls 20%

China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable

Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

Investor sentiment improves as stock rises 17%

First half 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.082 in 1H 2022)

China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023

Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2023 Results on Aug 29, 2023

China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of HK$0.052 per share at 1.3% yield

Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022

Consensus EPS estimates fall by 18%

Full year 2022 earnings: EPS and revenues miss analyst expectations

China Traditional Chinese Medicine Holdings Co. Limited Provides Earning Guidance for the Year Ended 31 December 2022

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year

Investor sentiment improved over the past week

China Traditional Chinese Medicine Holdings Co. Limited Announces Management Changes

Less than half of directors are independent

Consensus forecasts updated

These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively

China Traditional Chinese Medicine Holdings Co. Limited Do Not Recommend the Payment of an Interim Dividend for the Six Months Ended 30 June 2022

First half 2022 earnings released: EPS: CN¥0.082 (vs CN¥0.18 in 1H 2021)

China Traditional Chinese Medicine Holdings Co. Limited to Report First Half, 2022 Results on Aug 26, 2022

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially

Consensus revenue estimates fall by 11%

Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2021, Payable on 29 July 2022

Upcoming dividend of HK$0.074 per share

China Traditional Chinese Medicine Holdings Co. Limited Recommends Final Dividend for the Year Ended 31 December 2021

China Traditional Chinese Medicine Holdings Co. Limited Recommends Final Dividend for the Year Ended 31 December 2021

Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

China Traditional Chinese Medicine Holdings Co. Limited Announces Executive Changes

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorated over the past week

Now 20% undervalued

Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Investor sentiment deteriorated over the past week

Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Investor sentiment improved over the past week

Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate

I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease

First half 2021 earnings released: EPS CN¥0.18 (vs CN¥0.14 in 1H 2020)

Upcoming dividend of HK$0.067 per share